EP 1235577 A4 20030409 - PROTEASE INHIBITORS
Title (en)
PROTEASE INHIBITORS
Title (de)
PROTEASEINHIBITOREN
Title (fr)
INHIBITEURS DE PROTEASE
Publication
Application
Priority
- US 0030633 W 20001108
- US 16451199 P 19991110
Abstract (en)
[origin: WO0134565A2] This invention relates to the compound of Formula (I): or a pharmaceutically acceptable salt, hydrate or solvate thereof, which is an inhibitor of cysteine proteases, particularly cathepsin K, and is useful in the treatment of diseases in which inhibition of bone loss or of cartilage degradation is a factor.
IPC 1-7
A61K 31/55; C07D 409/14; A61P 19/08; A61P 19/10; C07D 495/04; A61K 31/38
IPC 8 full level
A61K 31/55 (2006.01); A61P 1/02 (2006.01); A61P 19/00 (2006.01); A61P 19/02 (2006.01); A61P 19/10 (2006.01); A61P 43/00 (2006.01); C07D 495/04 (2006.01)
CPC (source: EP)
A61P 1/02 (2017.12); A61P 19/00 (2017.12); A61P 19/02 (2017.12); A61P 19/08 (2017.12); A61P 19/10 (2017.12); A61P 43/00 (2017.12); C07D 495/04 (2013.01)
Citation (search report)
- [X] WO 9805336 A1 19980212 - SMITHKLINE BEECHAM CORP [US], et al
- See references of WO 0134565A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0134565 A2 20010517; WO 0134565 A3 20011004; EP 1235577 A2 20020904; EP 1235577 A4 20030409; JP 2003513956 A 20030415
DOCDB simple family (application)
US 0030633 W 20001108; EP 00975608 A 20001108; JP 2001536514 A 20001108